# GAVILAX

NDC: 17856-0310
Generic name: Polyethylene Glycol 3350
Labeler / Manufacturer: Atlantic Biologicals Corp.
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: POWDER, FOR SOLUTION
Routes: ORAL
Marketing started: 20091009

FDA application: ANDA091077

## Active ingredients

- POLYETHYLENE GLYCOL 3350: 17 g/17g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"17856-0310"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=17856-0310
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4c207478-6f0f-c3cf-e063-6394a90aa4f2